Elspar Lyophilisate For Solution For Injection 10000U Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Elspar: Lyophilisate for solution for injection (10000U)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

L-ASPARAGINASE (L- a SPARE a gi nase) is used to treat acute lymphocytic leukemia (ALL). It is used in combination with other chemotherapy agents.

In-Depth Information
Select a Medication

Elspar 10,000unit Powder for Injection

NDC: 000064612
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved





Sometimes used for but not FDA approved for the following conditions:
Acute Lymphocytic Leukemia (ALL)

Storage Information
Store unreconstituted product in refrigerator (36 to 46 degrees F)
Discard product if it contains particulate matter, is cloudy, or discolored
Reconstituted unused product should be stored at 36-46 degrees F and used within 8 hours
Elspar 10,000unit Powder for Injection

Reported Side Effects for Elspar 10,000unit Powder for Injection

Antibody Formation Incidence:
<25.0%*
Severity: MODERATE
Onset: DELAYED
Confusion Incidence:
>25.0%*
Severity: MODERATE
Onset: EARLY
Decreased Thinking Incidence:
>25.0%*
Severity: MODERATE
Onset: EARLY
Coma Incidence:
>25.0%*
Severity: SEVERE
Onset: EARLY
Anaphylactoid Reactions Incidence:
32.5-75.0%*
Severity: SEVERE
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Elspar

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5